Intrinsic Value of S&P & Nasdaq Contact Us

Elicio Therapeutics, Inc. ELTX NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
39/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$17.00
+44.3%

Stock Statistics — ELTX

Elicio Therapeutics, Inc. (ELTX) has a market capitalization of $216.71M and trades at $11.78. The 52-week range is 4.6-14.93.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -4.6, Earnings Per Share (EPS) of $-2.58.

The stock has a beta of 1.88, operates in the Healthcare sector.

Trading Data
Current Price$11.78
52-Week Range4.6-14.93
Volume75.47K
Avg Volume (30D)137.5K
Market Cap$216.71M
Beta (1Y)1.88
Company
IPO Date2021-02-05
Employees32
CEORobert T. Connelly
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS28657F1030
CUSIP28657F103
Income (Latest Year)
Gross Profit$-1.13M
EBITDA$-36.59M
Operating Income$-37.71M
Net Income$-39.57M
EPS$-2.58
EPS Diluted$-2.58
Shares Outstanding$15.31M
Balance Sheet (Latest Year)
Total Assets$25.86M
Current Assets$19.31M
Cash & ST Investments$18.56M
Total Liabilities$24.23M
Total Debt$14.51M
Net Debt$-4.05M
Total Equity$1.64M
Debt / Equity8.87
Valuation Ratios
P/E Ratio-4.6
P/B Ratio132.46
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message